Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible?
- 25 October 2014
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 443, 85-93
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- The past, present and future of renin–angiotensin aldosterone system inhibitionInternational Journal of Cardiology, 2013
- Aliskiren, ALTITUDE, and the Implications for ATMOSPHEREEuropean Journal of Heart Failure, 2012
- Elevated Plasma Renin Activity Predicts Adverse Outcome in Chronic Heart Failure, Independently of Pharmacologic Therapy: Data From the Valsartan Heart Failure Trial (Val-HeFT)Journal of Cardiac Failure, 2010
- Human microRNA-155 on Chromosome 21 Differentially Interacts with Its Polymorphic Target in the AGTR1 3′ Untranslated Region: A Mechanism for Functional Single-Nucleotide Polymorphisms Related to PhenotypesThe American Journal of Human Genetics, 2007
- Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletionHuman Genetics, 2004
- Diagnostic Accuracy and Prognostic Relevance of the Measurement of Cardiac Natriuretic Peptides: A ReviewClinical Chemistry, 2004
- A sensitive enzyme immunoassay for angiotensin II in serumJournal of Pharmaceutical and Biomedical Analysis, 1994
- Molecular basis of human hypertension: Role of angiotensinogenCell, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990
- Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.Circulation, 1981